CD-Chex CD117® Plus

CD-Chex CD117 Plus is a ready-to-use control for evaluating CD117, CD25 and CD71 expression by flow cytometry. Developed to resemble peripheral blood leukocytes often found in a hematolymphoid neoplastic patient sample, CD-Chex CD117 provides percent-positive values for CD117, CD25 and CD71 on abnormal and total leukocytes. Abnormal leukocytes are distinguishable from normal leukocytes based on light scatter properties and low CD45 expression.

CD-Chex CD117 is a positive procedural control designed to monitor reagent staining, erythrocyte lysis, sample preparation and instrument performance and is compatible with BD^® Biosciences and Beckman Coulter® flow cytometry systems.

Features

• Only commercially available control assayed for CD117, CD25 and CD71
• Resembles an abnormal peripheral blood patient sample
• Compatible with BD Biosciences and Beckman Coulter flow cytometry systems
• 30-day open-vial stability; 90-day closed-vial stability

Benefits

• Aids in meeting the quality requirements for leukemia and lymphoma immunophenotyping
• Manufacturer established assay ranges – no need to verify range per CAP requirements
• Reduces the need for labs to hold and validate patient samples for use as a control
• Access to STATS®, Streck’s free interlaboratory quality control program for peer group data comparison
• For Research Use Only. Not for use in diagnostic procedures.